Corporate Board Profile
Tech Score: 50/100
1 mention(s) identify VISHWAS SESHADRI as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. | 2022-07-11 | Dr. Seshadri completed his Ph.D. in Microbiology, Immunology & Molecular Biology and his post-doc in epigenetics. | Has a Ph.D. in Microbiology, Immunology & Molecular Biology and experience in research and development, including roles in CAR T cell therapy. |
| Filing Date | Source Excerpt |
|---|---|
| 2022-05-12 | Directors and Named Executive Officers: Vishwas Seshadri |
| 2022-07-11 | Dr. Seshadri completed his Ph.D. in Microbiology, Immunology & Molecular Biology and his post-doc in epigenetics. |
Data sourced from SEC filings. Last updated: 2025-07-01